Academia.eduAcademia.edu

Outline

Title
Abstract
Key Takeaways
Figures
Introduction and Summary
Summary
Studying Brain Disorders
Studying the Normal Human Brain
Policy Questions and Issues
Policy Questions
Background
Physical Methods
Conclusion
Foregone Futures
References

Brain Waves Module 1: Neuroscience, society and policy

Profile image of Emelya LohoEmelya Loho

Abstract
sparkles

AI

This report, part of the Royal Society's Brain Waves project, explores the intersection of neuroscience, society, and policy. It discusses advancements in neuroscience, their implications for improving mental health treatment and understanding human behavior, and the ethical concerns surrounding neurotechnology applications. The document serves as an introduction to broader discussions in subsequent modules about the impacts of neuroscience on various sectors including education, security, and legal responsibilities.

Key takeaways
sparkles

AI

  1. Neuroscience advancements promise improved treatment for neurodegenerative diseases and mental illnesses, impacting public policy.
  2. The Brain Waves project aims to explore neuroscience's potential benefits, risks, and ethical implications across diverse fields.
  3. Neural interfaces (NIS) could revolutionize treatment for paralysis by translating brain signals into movement control.
  4. Neuroethics raises concerns regarding privacy, free will, and responsibility in light of neuroscience's implications.
  5. Neuroscience may lead to both beneficial and harmful applications, necessitating careful policy considerations and governance.
Figures (6)
Figure 1 This is a MRI image of the visual cortex in one hemisphere of the brain. (The visual cortex is the part of the brain that is active when you look at something.) The dark grey stripes represent gray matter at the bottom of sulci and the light grey stripes represent gray matter associated with brain gyri. Overlaid on the inflated anatomical image are colored patches representing functional MRI signals associated with stimulatin different regions of the visual field. (Reproduced courtesy of Geraint Rees, University College London.)
Figure 1 This is a MRI image of the visual cortex in one hemisphere of the brain. (The visual cortex is the part of the brain that is active when you look at something.) The dark grey stripes represent gray matter at the bottom of sulci and the light grey stripes represent gray matter associated with brain gyri. Overlaid on the inflated anatomical image are colored patches representing functional MRI signals associated with stimulatin different regions of the visual field. (Reproduced courtesy of Geraint Rees, University College London.)

Related papers

Projections and the Potential Societal Impact of the Future of Neurotechnologies
David Eagleman

Frontiers in Neuroscience

Traditionally, recording from and stimulating the brain with high spatial and temporal resolution required invasive means. However, recently, the technical capabilities of less invasive and non-invasive neuro-interfacing technology have been dramatically improving, and laboratories and funders aim to further improve these capabilities. These technologies can facilitate functions such as multi-person communication, mood regulation and memory recall. We consider a potential future where the less invasive technology is in high demand. Will this demand match that the current-day demand for a smartphone? Here, we draw upon existing research to project which particular neuroethics issues may arise in this potential future and what preparatory steps may be taken to address these issues.

View PDFchevron_right
Long and winding road: From neuroscience to policy, program and practice
Bruce Perry

Insight: Victorian Council of Social Services Journal 9: 4-8, 2014

View PDFchevron_right
Neuroscience beyond the laboratory: Neuro knowledges, technologies and markets
Tanja Schneider

BioSocieties, 2015

View PDFchevron_right
Monitoring and manipulating the human brain: new neuroscience technologies and their ethical implications
Paul Root Wolpe

2004

View PDFchevron_right
Brain, Mind and Society. A critical account of neuroscience (2014)
Vincent Pidoux

Published in EspacesTemps.net (Traverse Brain and Mind in Society), 2014

View PDFchevron_right
Who will guard the guardians of neuroscience? Firing the neuroethical imagination
Raymond De Vries

EMBO reports, 2007

View PDFchevron_right
The neuroscience revolution
Paul Wolpe

The Hastings Center report, 2002

View PDFchevron_right
Neuroscience and Society
David Parker
View PDFchevron_right
The neurotechnology and society interface: responsible innovation in an international context
Diana Bowman

Journal of Responsible Innovation

Advances in brain science and research tools promise to increase our understanding of the human brain, treat brain injury and mental illnesses, and enhance cognition, perception, mood, and alertness. Novel neurotechnologies present opportunities but also profound societal questions and require stakeholders to deeply consider ethical, legal, and medical challenges. The current Special Issue of Journal of Responsible Innovation explores the interface of neurotechnology and society in an international context, defining neurotechnology broadly as technical tools aimed at generating better knowledge of the brain and/or intervening in its function. The Issue features a unique and globally drawn group of authors from the public, private, philanthropic, and academic sectors. Together, and befitting the complex challenges of innovating responsibly in a social context, they explore neurotechnology as a simultaneously technical and social practice.

View PDFchevron_right
Neuroethics for the National Institutes of Health BRAIN Initiative
David Shurtleff

The Journal of Neuroscience, 2018

Background on the National Institutes of Health BRAIN Initiative and neuroethics The National Institutes of Health (NIH) works tirelessly to support the best science and ensure that its funded research adheres to the highest ethical standards. From its inception, the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, an ambitious effort focused on understanding the human brain, has made a concerted effort to integrate neuroethics into its science, motivated by the understanding that brain circuit activity is the foundation of individual human experiences and is uniquely entwined with our sense of personal identity. In the 5 years since the Initiative began, NIH has invested over $950 million in BRAIN Initiative research throughout the United States and around the world to develop novel tools and neurotechnologies that will enable unprecedented detailed maps of neural circuits, measures of the fluctuating patterns of electrical and chemical activity flowing within those circuits, and understanding of how their interplay creates our cognitive and behavioral capabilities. Understanding neural circuit function is essential if we are to transform our ability to diagnose and treat neurological, mental health, and substance use disorders, which are the leading cause of disability in the United States. For this diverse group of disorders, the burden of illness results

View PDFchevron_right

References (52)

  1. References and further reading European Community Health Indicators, available at: http://ec.europa.eu/health/ ph_information/dissemination/echi/query/ Zeki S and Goodenough O (eds) (2004) Law and the brain. Philosophical Transactions of the Royal Society B, Vol 359. References and further reading Academy of Medical Sciences (2008) Brain science, addiction and drugs. London: Academy of Medical Sciences.
  2. Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P and Farah M (2008) Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, Vol 456, pp 702-705.
  3. Jones R, Morris K and Nutt D (2007) Cognition enhancers. In: Nutt D, Robbins T, Stimson G, Ince M, and Jackson A (eds) Drugs and the Future. Amsterdam: Elsevier. pp 241-283.
  4. Maher B (2008) Poll results: look who's doping. Nature, Vol 452, pp 674-675.
  5. Mattay V, Goldberg T, Fera F, Hariri A, Tessitore A and Egan M (2003) Catechol-O- methyl trasferase Val 158-Met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences, Vol 100, pp 6186-6191.
  6. Nutt D, Robbins T, Stimson G, Ince M and Jackson A (eds) (2006) Drugs and the Future: Brain science, addiction and society. Burlington MA: Academic Press.
  7. Robbins T, Everitt B, Nutt D (2010) The Neurobiology of Addiction; New vistas. Oxford: Oxford University Press. Royal Society (2005) Personalised medicines: hopes and realities.
  8. Sahakian B and Morein-Zamir S (2007) Professor's little helper. Nature, Vol 450, pp 1157-1159.
  9. Saper C, Cano G, and Scammel T (2005) Homeostatic, circadian and emotional regulation of sleep. Journal of Comparative Neurology, Vol 493, pp 92-98.
  10. Stahl S (2008) Stahl's Essential Psychopharmacology: Neuroscientifi c basis and practical application. 3rd edition. Cambridge: Cambridge University Press.
  11. Sugden C, Aggarwal R, Housden C, Sahakian B and Darzi A (2010) Pharmacological enhancement of performance in doctors. British Medical Journal, Vol 340, p 2542. References and further reading Dennett D (1969) Content and Consciousness. London: Routledge.
  12. Greely H, The Social Effects of Advances in Neuroscience: legal problems, legal perspectives. In: Illes J (ed), Neuroethics: Defi ning the Issues in Theory, Practice and Policy. Oxford: Oxford University Press.
  13. Harris J (1985) The Value of Life. London: Routledge.
  14. Radin M (1982) Property and Personhood. Stanford Law Review, Vol 34, p 957.
  15. Ryle G (1969) The Concept of Mind. London: Hutchinson. References and further reading Bayes A and Grant S (2009) Neuroproteomics: understanding the molecular organization and complexity of the brain. Nature Reviews Neuroscience, Vol 10, pp 635-646.
  16. Beddington J, Cooper C, Field J, Goswani U, Huppert F, Jenkins R, Jones H, Kirkwood T, Sahakian B and Thomas S (2008) The mental wealth of nations. Nature, Vol 455, pp 1057-1060.
  17. Berman R, Cappiello A, Anand A, Oren D, Heninger G, Charney D and Krystal J (2000) Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, Vol 47, No 4, pp 351-354.
  18. Boyden E, Zhang F, Bamberg E, Nagel G and Deisseroth K (2005) Millisecond- timescale, genetically-targeted optical control of neural activity. Nature Neuroscience, Vol 8, No 9, pp 1263-1268.
  19. Drevets W and Furey M (2010) Replication of scopolamine's antidepressant effi cacy in major depressive disorder: A randomized, placebo-controlled clinical trial. Biological Psychiatry, Vol 67, No 5, pp 432-438.
  20. Fernandez E, Collins M, Uren R, Kopanitsa M, Komiyama N, Croning M, Zografos L, Armstrong J, Choudhary J and Grant S (2009). Targeted tandem affi nity purifi cation of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins. Molecular Systems Biology, Vol 5, p 269.
  21. Gradinaru V, Zhang F, Ramakrishnan C, Mattis J, Prakash R, Diester I, Goshen I, Thompson K and Deisseroth K (2010) Molecular and cellular approaches for diversifying and extending optogenetics. Cell, Vol 141, pp 1-12. Health Economics Research Group, Offi ce of Health Economics, RAND Europe (2008) Medical Research: What's it worth? Estimating the economic benefi ts from medical research in the UK. London: UK Evaluation Forum.
  22. Klingberg T (2010) Training and plasticity of working memory. Trends in Cognitive Sciences, Vol 14, pp 317-324.
  23. Kravitz A, Freeze B, Parker P, Kay K, Thwin M, Deisseroth K and Kreitzer A (2010) Regulation of Parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature, Vol 466, pp 622-626.
  24. Lagali P, Balya D, Awatramani G, Münch T, Kim D, Busskamp V, Cepko C and Roska B (2008) Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration. Nature Neuroscience, Vol 11, pp 667-675.
  25. MRC (2010) MRC Review of Mental Health Research -Report of the Strategic Review Group. London: Medical Research Council.
  26. Miller G (2010) Is Pharma running out of brainy ideas. Science, Vol 329, pp 502- 504. Olsen A, Eadie B, Ernst C and Christie B (2006) Environmental Enrichment and Voluntary Exercise Massively Increase Neurogenesis in the Adult Hippocampus via Dissociable Pathways. Hippocampus, Vol 16, pp 250-260.
  27. Petreanu L, Mao Y, Sternson S, Svoboda K (2009) The subcellular organization of neocortical excitatory connections. Nature, Vol 457, pp 1142-1145.
  28. References and further reading
  29. Collins F (2010) The Language of Life: DNA and the revolution in personalised medicine. HarperCollins.
  30. Crick F (1994) The Astonishing Hypothesis: the scientifi c search for the soul. London: Simon and Schuster.
  31. Davison N (2009) 'Non-lethal' Weapons. Basingstoke: Palgrave Macmillan.
  32. Gibson W (2000) Neuromancer. Voyager.
  33. Habermas J (2003) The Future of Human Nature. Cambridge: Polity Press.
  34. Miller G (2010) Is Pharma running out of brainy ideas? Science, Vol 329, pp 502- 504. Rose S (2002) Smart drugs: do they work? Are they ethical? Will they be legal? Nature Reviews Neuroscience, Vol 3, pp 975-978.
  35. Rose S (2006) The 21st Century Brain: Explaining, mending and manipulating the mind. London: Vintage. References and further reading
  36. Chan S and Harris J (2006) Cognitive regeneration or enhancement: the ethical issues. Regenerative Medicine. Vol 1, No 3, pp 361-366.
  37. Chan S, Sulston J, and Harris J (forthcoming) Ethical Incentives for Innovation. In: Stiglitz, J et al. (eds) Intellectual Property Rights: Legal and Economic Challenges for Development. Oxford: Oxford University Press.
  38. Cunningham-Burley S (2010) Engaging with neuroscience: examining neurological subjectivity and what this means for debates about enhancement technologies (conference paper at 'Beyond The Body: Perspectives on Enhancement', 9-11 April 2010, Manchester).
  39. Dana Centre (2002) Neuroethics: Mapping the Field. Brainwork, Special Issue.
  40. Farah M (2005) Neuroethics: the practical and the philosophical. Trends in Cognitive Science, Vol 9, No 1, pp 34-30.
  41. Farahany N and Bernet W (2006) Behavioural Genetics in Criminal Cases: Past, Present and Future. Genomics, Society and Policy, Vol 2, No 1, pp 72-79. Regarding the case of Stephen Mobley. Foresight Mental Capital and Wellbeing Project (2008) Final Project Report. London: Government Offi ce for Science.
  42. Fukuyama F (2002) Our Posthuman Future. London: Profi le Books.
  43. Greely H, Sahakian B, Harris J, Kessler R, Gazzaniga M, Campbell P, and Farah M (2008) Towards responsible use of cognitive enhancing drugs by the healthy. Nature, Vol 456, pp 702-705.
  44. Habermas J (2003) The Future of Human Nature. Cambridge: Polity Press.
  45. Harris J (2007) Enhancing Evolution. Princeton NJ: Princeton University Press, Chapter 7.
  46. Harris J (2011) Moral Enhancement and Freedom, Bioethics, Vol 25, No 2, pp 102-111.
  47. Illes J and Raffi n T (2002) Neuroethics: an emerging new discipline in the study of brain and cognition. Brain and Cognition, Vol 50, No 3, pp 341-344.
  48. Kass, L (2003) Ageless Bodies, Happy Souls. The New Atlantis. Spring. Perrson I and Savulescu J (2008) The perils of Cognitive Enhancement and the Urgent Imperative to Enhance the Moral Character of Humanity. Journal of Applied Philosophy, Vol 25, No 3, pp 162-177.
  49. Rees M (2004) Our Final Century. London: Arrow Books.
  50. Royal Society (2003) Keeping Science Open: the effects of intellectual property policy on the conduct of science. London: Royal Society.
  51. Strawson P (1960) Freedom and Resentment. Proceedings of the British Academy, Vol 48, pp 1-25.
  52. The Manchester Manifesto (2009) Available at: http://www.isei.manchester. ac.uk/TheManchesterManifesto Wensley D and King M (2008) Scientifi c responsibility for the dissemination and interpretation of genetic research: lessons from the 'warrior gene' controversy. Journal of Medical Ethics, Vol 34, No 6, pp 507-509. References and further reading BIS (2009) Stilgoe J (ed), The Road Ahead: Public Dialogue on Science and Technology, Department for Business, Innovation and Skills. London: HMSO. EEA (2001) Gee D, Harremoes P, Keys J, MacGarvin M, Stirling A, Vaz S, and Wynne B Late Lesson from Early Warnings: the precautionary principle 1898-2000. Copenhagen: European Environment Agency. EGSG (2007). Expert Group on Science and Governance (Felt U, Wynne B, Callon M, Goncalves M, Jasanoff S, Jepsen M, Joly P-B, Konopasek Z, May S, Neubauer C, Rip A, Siune K, Stirling A, and Tallachini M (2007) Science and Governance: taking European Knowledge Society Seriously, Report to the European Commission DG Research. ESTO (1999) European Science and Technology Observatory, On Science and Precaution in the Management of Technological Risk: Volume I-a synthesis report of case studies. Seville: European

Related papers

Unpacking Neuroscience and Neurotechnology - Instructions not Included: Neuroethics Required
James Giordano

Neuroethics, 2013

Using a metaphorical reminiscence upon holiday toys-and the hopes, challenges and possibilities they presented-this essay addresses the ways that the heuristics, outcomes and products of neuroscience have effected change in the human condition, predicament, and being. A note of caution is offered to pragmatically assess what can be done with neurotechnology, what can't, and what should and shouldn't-based upon the capacities and limitations of both the science, and our collective ability to handle knowledge, power and the unknown. This is not an appeal to impede brain research. To the contrary, it is a call to engage neuroethics as a discipline and set of practices 1) to allow a deeper, more finely-grained understanding of brains and their functions in ecological dynamics (that we define as morality and ethics), and 2) to intuit how to engage neuroscientific research and its applications in the social sphere (inclusive of medicine, public life and national agenda), to more accurately perceive how neuroscience is changing human society and the human being, and to instantiate more relevant ethics and laws that are in step with advancing epistemological capital and technological capability.

View PDFchevron_right
Innovations in neuroscience: prospects and perils
Reinhard Merkel

Poiesis & Praxis, 2006

The articles gathered in this focus section are based on presentations which their authors contributed to an international expert workshop held in Brussels on April 7th/8th, 2005. This workshop was part of an interdisciplinary research project on ''Intervening in the Psyche. Novel Possibilities as Social Challenges'' that is currently run by the Europa¨ische Akademie GmbH. As its title suggests, the project deals with new techniques of intervening in the human psyche whose development has been facilitated and accelerated by the wealth of insights into the brain's functioning that neuroscience has gained during the last few decades. The project aims to review these scientific and technological advances, indicate future developments, and discuss ethical and legal concerns raised in the public debate on these innovations. To achieve this, medical experts who have got firsthand experience of applying the techniques at issue teamed up with philosophers and law experts for a total period of 2.5 years. 1 On occasion of the aforesaid workshop in Brussels, the members of this project group [which happens to be chaired by one of us (R.M.) and coordinated by the other (T.G.)] invited the authors of the following papers to discuss the whole range of the issues covered by their project. 1 The results of this collaboration presumably will get published by the end of this year as volume no. 29 of the Europa¨ische Akademie's book series Wissenschaftsethik und Technikfolgenbeurteilung.

View PDFchevron_right
Neurotechnology and Society: Strengthening Responsible Innovation in Brain Science
Diana Bowman

Neuron, 2016

Technological advances have the potential to dramatically increase our understanding of the human brain, treat and cure injury and disease, and enhance our general well-being. While advances in neuroscience hold great promise, they also raise profound ethical, legal, and social questions. In this vein, the Organization for Economic Cooperation and Development (OECD) convened an international workshop in September 2016 to explore responsible research and innovation in brain science.

View PDFchevron_right
Neurotechnology: New Frontiers for European Policy
Roland Benedikter
View PDFchevron_right
Bovet E, Kraus C., Panese F., Pidoux V., Stücklin N., «Neuroscience examined by the clinical and the social science. Crossed perspectives», Revue d'anthropologie des connaissances 3/2013 (Vol. 7, n° 3), p. 555-569 (Edition of the special issue «Les sciences du cerveau»).
Francesco Panese
View PDFchevron_right

Related topics

  • Neuroscience
    • 580 California St., Suite 400
    San Francisco, CA, 94104
    © 2025 Academia. All rights reserved